









Markets
/
Stocks
/
nasdaq-ardt
/

Ardent Health Partners Inc

ARDT

14.755USD

-0.255-1.70%

Market hours （ET）Quotes delayed by 15 min

2.11BMarket Cap

8.28P/E TTM



Ardent Health Partners Inc

14.755

-0.255-1.70%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Ardent Health Partners Inc

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Ardent Health Partners Inc's Score

Industry at a Glance

Industry Ranking

25 / 78

Overall Ranking

130 / 4623

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 13 analysts

Buy

Current Rating

19.417

Target Price

+28.67%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Ardent Health Partners Inc Highlights

StrengthsRisks

Ardent Health Partners, Inc., formerly Ardent Health Partners, LLC, is a provider of healthcare services in the United States. The Company operates in eight mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a broad network of ambulatory facilities and telehealth services, including 146 primary care and specialty care clinics, three ambulatory surgery centers (ASCs), 40 urgent care centers, two freestanding emergency departments, and ten diagnostic imaging centers. The Company also operates a consumer-centric healthcare platform focused on creating long-lasting relationships with its patients across multiple care settings.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 16.30% year-on-year.

Fairly Valued

The company’s latest PE is 7.87, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 105.73M shares, decreasing 2.31% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 23.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-29

The company's current financial score is 7.37, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.65B, representing a year-over-year increase of 11.85%, while its net profit experienced a year-over-year increase of 70.56%.

Score

Industry at a Glance

Previous score

0.00

Change



Financials

9.13

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.38

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.05

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.28

Key Metrics

Free cash flow

No Data

Ardent Health Partners Inc's Company Valuation

Currency: USD Updated: 2025-10-29

The company’s current valuation score is 6.68, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 7.87, which is 703.45% below the recent high of 63.20 and 31.91% above the recent low of 5.36.

Score

Industry at a Glance

Previous score

0.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 25/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-29

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Ardent Health Partners Inc is 20.00, with a high of 23.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 13 analysts

Buy

Current Rating

19.417

Target Price

+29.36%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Ardent Health Inc

ARDT

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-29

The company’s current price momentum score is 8.72, which is higher than the Healthcare Providers & Services industry's average of 7.13. Sideways: Currently, the stock price is trading between the resistance level at 16.01 and the support level at 13.49, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.017

Buy

RSI(14)

65.466

Neutral

STOCH(KDJ)(9,3,3)

69.950

Sell

ATR(14)

0.430

High Vlolatility

CCI(14)

97.476

Neutral

Williams %R

24.737

Buy

TRIX(12,20)

0.510

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

15.052

Sell

MA10

14.899

Sell

MA20

14.560

Buy

MA50

13.624

Buy

MA100

13.034

Buy

MA200

13.505

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-29

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 73.88%, representing a quarter-over-quarter decrease of 23.47%. The largest institutional shareholder is The Vanguard, holding a total of 936.33K shares, representing 0.65% of shares outstanding, with 229.12% increase in holdings.

Score

Industry at a Glance

Previous score

0.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Chai Trust Company, LLC

77.25M

Pure Health Holding PJSC

30.26M

Ventas Inc

9.34M

Columbia Threadneedle Investments (US)

1.63M

+75.58%

Castleknight Management LP

1.23M

+23.75%

Millennium Management LLC

1.19M

+24.17%

BlackRock Institutional Trust Company, N.A.

1.19M

-2.08%

GoldenTree Asset Management, LP

1.15M

-14.50%

Petrovich (Stephen C)

1.07M

-0.07%

Bonick Martin

1.06M

+14.57%

Risk Assessment

Currency: USD Updated: 2025-10-29

The company’s current risk assessment score is 5.93, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.